Biofrontera (BFRI) Income from Continuing Operations (2020 - 2025)

Biofrontera's Income from Continuing Operations history runs 6 years deep, the most recent figure standing at 7872000.0 for Q4 2025.

• On a quarterly basis, Income from Continuing Operations rose 663.9% year-over-year to 7872000.0 in Q4 2025; TTM through Dec 2025 was 8304000.0, a 53.24% increase from a year earlier, with the FY2025 full-year figure at 8304000.0, up 53.24% from the prior year.
• Income from Continuing Operations climbed to 7872000.0 in Q4 2025 per BFRI's latest filing, from 6649000.0 in the prior quarter.
• Across five years, Income from Continuing Operations topped out at 7872000.0 in Q4 2025 and bottomed at 16012000.0 in Q3 2021.
• The 5-year median for Income from Continuing Operations is 3932000.0 (2021), against an average of 4227300.0.
• Across the five-year window, Income from Continuing Operations tumbled 7698.39% in 2021 and surged 663.9% in 2025, its largest moves.
• Year by year, Income from Continuing Operations stood at 14505000.0 in 2021, then soared by 80.8% to 2785000.0 in 2022, then jumped by 226.61% to 3526000.0 in 2023, then plunged by 139.59% to 1396000.0 in 2024, then jumped by 663.9% to 7872000.0 in 2025.
• Per Business Quant, the three latest BFRI Income from Continuing Operations figures stand at 7872000.0 (Q4 2025), 6649000.0 (Q3 2025), and 5324000.0 (Q2 2025).